NextCure (NXTC) Cash & Equivalents (2018 - 2026)
NextCure (NXTC) reported Cash & Equivalents of $8.73 million for Q3 2026, up 19.2% from $7.32 million a year earlier but down 42.8% from the prior quarter.
NextCure (NXTC) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, NextCure posted Cash & Equivalents of $25.98 million, down 6.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $27.73 million in FY2024 (+111.9%), $13.08 million in FY2023 (-50.9%), $26.63 million in FY2022 (+115.9%) and $12.34 million in FY2021 (-62.4%).
- Five-year quarterly Cash & Equivalents spans a low of $4.89 million in Q2 2025 and a high of $31.05 million in Q3 2022.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 21.9%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2026 (growth of 211.9%); the low point was Q2 2025 (a decline of 76.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $15.26 million (Q2 2026), $15.17 million (Q1 2026) and $25.98 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.82 Bn |
| 10 | NextCure | 29.30 Mn | -71.08 Mn | - | 8.73 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.73 Mn |
| Jun 30, 2026 | 15.26 Mn |
| Mar 31, 2026 | 15.17 Mn |
| Dec 31, 2025 | 25.98 Mn |
| Sep 30, 2025 | 7.32 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 21.83 Mn |
| Dec 31, 2024 | 27.73 Mn |
| Sep 30, 2024 | 27.70 Mn |
| Jun 30, 2024 | 20.85 Mn |
| Mar 31, 2024 | 18.36 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Sep 30, 2023 | 19.52 Mn |
| Jun 30, 2023 | 22.02 Mn |
| Mar 31, 2023 | 29.97 Mn |
| Dec 31, 2022 | 26.63 Mn |
| Sep 30, 2022 | 31.05 Mn |
| Jun 30, 2022 | 28.16 Mn |
| Mar 31, 2022 | 10.65 Mn |
| Dec 31, 2021 | 12.34 Mn |
NextCure Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();